A Biocatalytic Approach to a Key Intermediate for the Synthesis of the COVID-19 Experimental Drug Molnupiravir
Ashleigh J. Burke(Scripps Institution of Oceanography), Anthony P. Green(University of Manchester), Bruna Zuculoto da Costa(University of Manchester), James Finnigan(Prozomix (United Kingdom)), Ian Rowles(University of Manchester), Simon J. Charnock(Prozomix (United Kingdom)), Sarah L. Lovelock(University of Manchester), Nicholas J. Turner(University of Manchester), Ying Zhuo(East China University of Science and Technology), William P. Birmingham(University of Manchester), T. E. Thorpe(University of Manchester), Rebecca Crawshaw(University of Manchester)
Cited by 5
Related Papers
A CRISPR-Cas12a-derived biosensing platform for the highly sensitive detection of diverse small molecules
|Nature Communications|2019|424
The road to fully programmable protein catalysis
|Nature|2022|357
Enantioselective Chemo‐ and Biocatalysis: Partners in Retrosynthesis
|Angewandte Chemie International Edition|2017|287
A designed photoenzyme for enantioselective [2+2] cycloadditions
|Nature|2022|213